Skipping rad therapy may not hinder breast cancer survival
Forgoing radiation therapy after breast-conserving surgery may not negatively...Read more on AuntMinnie.comRelated Reading:
Contrast-enhanced mammo can play pivotal diagnostic role
Radiation therapy takes toll on prostate cancer patients' finances
Radiation therapy access grows, but not in rural areas
Breast MRI works as presurgical tool
CEDM excels as presurgical diagnosis tool in large study (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 9, 2020 Category: Radiology Source Type: news
Omitting radiation therapy after breast-conserving surgery may not impact 10-year survival rates for older patients with HR-positive breast cancer
(American Association for Cancer Research) Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 9, 2020 Category: Cancer & Oncology Source Type: news
Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer
Risk higher in first five years of follow - up for those treated with breast - conserving surgery alone (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 16, 2020 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Conference News, Source Type: news
Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer
FRIDAY, Oct. 16, 2020 -- For women with ductal carcinoma in situ (DCIS), the risk for developing subsequent ipsilateral in situ (iDCIS) and invasive breast cancer (iBC) is lower for those receiving breast-conserving surgery (BCS) and radiotherapy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2020 Category: Pharmaceuticals Source Type: news
Study Helps Gauge Long-term Risks for Women With DCIS Study Helps Gauge Long-term Risks for Women With DCIS
New research helps clarify the long-term risk for invasive breast cancer in women with ductal carcinoma (DCIS) in situ who opt for breast-conserving surgery alone or with radiotherapy.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 8, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news
Breast cancer surgery type, quality of life among younger women
(JAMA Network) Researchers investigated differences in quality of life and other outcomes (including physical functioning, body image, sexual health, anxiety and depressive symptoms) by type of breast cancer surgery (such as mastectomy or breast conserving surgery) in women 40 and younger. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 16, 2020 Category: Cancer & Oncology Source Type: news
‘Could It Work as a Cure? Maybe.’ A Herbal Remedy for Coronavirus Is a Hit in Africa, But Experts Have Their Doubts
On April 20, the president calls a press conference to announce a breakthrough in the fight against COVID-19. It’s a new use for an old malaria treatment, he says, one that is seeing miraculous results among the country’s most ill patients. It’s so safe that even schoolchildren could take it. In fact, he urges them to do so daily, as a preventative. He admits that he, too, is taking the medicine.
No, this is not the President of the United States touting an unproven remedy for a virus that has infected nearly 5 million people worldwide. It is Madagascar’s President Andry Rajoelina, who is just as wi...
Source: TIME: Health - May 22, 2020 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized COVID-19 overnight Source Type: news
Medtech Perseveres During COVID-19
The COVID-19 pandemic is “an unprecedented crisis, and we’ve never seen anything like it,†Pat Shafer, managing director in Grant Thornton's healthcare and life sciences industry business, told MD+DI recently.
Judging from the amount of stories MD+DI has published alone in the last several weeks on the rapid responses from many medical device and diagnostics companies as well as industry suppliers, manufacturers are working quickly toward several potential solutions.
The medical device industry has been very agile in responding to the pandemic, Shafer said. â€...
Source: MDDI - April 21, 2020 Category: Medical Devices Authors: Daphne Allen Tags: Business Source Type: news
High-res imaging with elastography may accurately detect breast cancer in surgical margins
(American Association for Cancer Research) A high-resolution, three-dimensional imaging technique, when combined with quantitative measurement of tissue elasticity, could accurately detect cancer within the resected margins of surgical specimens taken from patients undergoing breast-conserving surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2020 Category: Cancer & Oncology Source Type: news
Breast Conservation After Neoadjuvant Chemotherapy Less Common in US Than Elsewhere Breast Conservation After Neoadjuvant Chemotherapy Less Common in US Than Elsewhere
Neoadjuvant systemic therapy can facilitate breast conservation in certain women with stage II and III operable breast cancer. But compared to other countries, significantly fewer women in the United States make such a choice.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 15, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Despite effective therapy, US rate of breast conservation lower than other countries
(Brigham and Women's Hospital) Patients treated in Europe or Asia were 2.6 times as likely to undergo breast conserving therapy rather than a mastectomy compared to those treated in North America when adjusted for clinically significant factors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 8, 2020 Category: Cancer & Oncology Source Type: news
Breast-conserving treatment without surgery not supported at this time
(NRG Oncology) Results from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radiological complete response (rCR)/near rCR, and negative tumor bed biopsies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 13, 2019 Category: Cancer & Oncology Source Type: news
Accelerated PBI not equivalent, but close, to WBI to control ipsilateral breast tumor recurrence
(NRG Oncology) Long-term results from the NRG Oncology clinical trial NSABP B-39/RTOG 0413 comparing whole-breast irradiation (WBI) to accelerated partial-breast irradiation (APBI) indicated that, although the absolute difference between treatment was less than 1%, APBI did not meet the criteria for equivalence to WBI in controlling ipsilateral breast tumor recurrence (IBTR) after breast-conserving therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2019 Category: Cancer & Oncology Source Type: news
Hologic Renews Focus for Breast Health with CE Mark Extension
Hologic is wasting little time putting the focus back on its breast health offerings. The Marlborough, MA-based company received an extension of a CE mark for the LOCalizer radiofrequency identification (RFID) tag for long-term placement.
The tag can now be implanted more than 30 days before a breast-conserving surgery, providing even greater flexibility and convenience to patients and providers.
The LOCalizer wire-free guidance system is a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. It was designed to replace the traditional wire-g...
Source: MDDI - December 2, 2019 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Source Type: news
Breast cancer recurrence after lumpectomy & RT is treatable with localized RT without mastectomy
(NRG Oncology) Approximately 10% of breast cancer patients treated with lumpectomy (breast-conserving surgery [BCS]) and whole-breast radiation (WBI) will have a subsequent in-breast local recurrence of cancer (IBTR) when followed long term. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 22, 2019 Category: Cancer & Oncology Source Type: news
No Benefit Seen for SLNB in BCS for DCIS in Older Women
Long - term outcomes similar with, without sentinel lymph node biopsy in breast - conserving surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 31, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Geriatrics, Journal, Source Type: news
No Benefit Seen for SLNB in BCS for DCIS in Older Women
THURSDAY, Oct. 31, 2019 -- For older patients with ductal carcinoma in situ (DCIS) who undergo breast-conserving surgery (BCS), sentinel lymph node biopsy (SLNB) is not associated with improvements in long-term outcomes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2019 Category: Pharmaceuticals Source Type: news
Treatment of Male Breast Cancer Has Evolved From 2004 to 2014
Significant increases seen in total mastectomy, radiotherapy after breast conservation, endocrine tx (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 7, 2019 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Nursing, Oncology, Journal, Source Type: news
Hologic Sets M & amp;A Sights on SuperSonic Imagine in $85M Deal
In an attempt to boost its imaging offerings for breast health, Hologic has made a binding offer to acquire SuperSonic Imagine for $85 million. Aix-En-Provence, France-based Sonic Imagine develops cart-based ultrasound products.
Hologic also would make available funds to repay SuperSonic Imagine’s net debt in an amount not to exceed $43 million, equating to a maximum enterprise value of $85 million. SuperSonic Imagine’s main shareholders, who together hold 10,841,409 shares or about 46% of the outstanding share capital of the company, have agreed to sell their shares to Hologic at the pr...
Source: MDDI - June 21, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Cianna points to new APBI research
Breast tumor localization and breast conservation therapy technology developer...Read more on AuntMinnie.comRelated Reading:
Cianna touts SAVI Scout results at SABCS
Merit Medical wraps up purchase of Cianna Medical
Merit Medical to acquire Cianna Medical
FDA OKs Cianna's Scout for soft-tissue localization
Cianna marks SAVI Scout milestone (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2019 Category: Radiology Source Type: news
10-Year Results Confirm WBI Benefit in Low-Risk Breast Cancer 10-Year Results Confirm WBI Benefit in Low-Risk Breast Cancer
Radiotherapy plus antihormones improve local control rates after breast conserving surgery in low-risk HR+ breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 29, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Emperor Penguin Population Sees Steep Decline in Antarctica ’s Second-Largest Breeding Ground
(WASHINGTON) — For the past three years, virtually nothing has hatched at Antarctica’s second biggest breeding grounds for emperor penguins and the start of this year is looking just as bleak, a new study found.
Usually 15,000 to 24,000 breeding pairs of emperor penguins flock yearly to a breeding site at Halley Bay , considered a safe place that should stay cold this century despite global warming. But almost none have been there since 2016, according to a study in Wednesday’s Antarctic Science.
The breeding pair population has increased significantly at a nearby breeding ground, but the study’s au...
Source: TIME: Science - April 25, 2019 Category: Science Authors: Seth Borenstein / AP Tags: Uncategorized animals onetime overnight Source Type: news
Margin Guidelines Affect Breast-Cancer Surgical Trends Margin Guidelines Affect Breast-Cancer Surgical Trends
Rates of breast-conserving surgery for early-stage breast cancer increased and repeat surgery decreased following dissemination of 2014 margin guidelines, according to new findings.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 3, 2019 Category: Surgery Tags: Hematology-Oncology News Source Type: news
Current Strategies for the Management of Locoregional Breast Cancer Recurrence
In this review, we focus primarily on describing locoregional and systemic management strategies for isolated locoregional recurrences manifesting as isolated first-failure events following mastectomy or breast-conserving therapy. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Irene L. Wapnir, MD, Atif Khan, MD, MS Source Type: news
Tumors backfire on chemotherapy
Some patients with breast cancer receive chemotherapy before the tumor is removed with surgery. This approach, called 'neoadjuvant' therapy, helps to reduce the size of the tumor to facilitate breast-conserving surgery, and can even eradicate the tumor, leaving few or no cancerous cells for the surgeon to remove. In those cases, the patients are very likely to remain cancer-free for life after surgery. (Source: World Pharma News)
Source: World Pharma News - January 2, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
High cost of re-operation after breast-conserving surgery
(Wiley) A small number of women require re-operation after breast-conserving surgery (BCS) for breast cancer, if the surgical margins are not free from cancer. A new BJS (British Journal of Surgery) analysis reveals the expense of re-operation. If re-operation rates can be minimized, there may be considerable efficiency savings. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 19, 2018 Category: Cancer & Oncology Source Type: news
What Effect Do Surgical Choices Have on Quality of Life in Young Breast Cancer Survivors?
Unilateral or bilateral mastectomy can have a significant effect on quality of life when compared with breast-conserving surgery in young breast cancer survivors. (Source: CancerNetwork)
Source: CancerNetwork - December 7, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news
Patients Say Quality of Life Suffered With Mastectomy for Early Breast Cancer
(MedPage Today) -- Breast-conservation options were associated with better sexual, psychosocial outcomes (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 7, 2018 Category: Hematology Source Type: news
For Younger Cancer Patients, Mastectomy vs. Breast - Conserving Surgery
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 7, 2018 Category: Cancer & Oncology Tags: Oncology, Surgery, News, Source Type: news
For Younger Cancer Patients, Mastectomy vs. Breast-Conserving Surgery
FRIDAY, Dec. 7, 2018 -- Younger breast cancer patients who have one or both breasts removed have lower levels of satisfaction and well-being than those who have breast-conserving surgery, a new study finds.
The study included 560 women diagnosed... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2018 Category: General Medicine Source Type: news
For Younger Cancer Patients, Mastectomy vs. Breast-Conserving Surgery
Title: For Younger Cancer Patients, Mastectomy vs. Breast-Conserving SurgeryCategory: Health NewsCreated: 12/7/2018 12:00:00 AMLast Editorial Review: 12/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 7, 2018 Category: Cancer & Oncology Source Type: news
Choice of surgery may affect quality of life for young breast cancer survivors
(American Association for Cancer Research) Younger breast cancer patients who underwent mastectomy reported lower breast satisfaction and poorer psychosocial and sexual well-being compared with those who underwent breast-conserving surgery, according to results of a trial presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 7, 2018 Category: Cancer & Oncology Source Type: news
For Younger Cancer Patients, Mastectomy vs. Breast-Conserving Surgery
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 7, 2018 Category: Cancer & Oncology Source Type: news
For Younger Cancer Patients, Mastectomy vs. Breast-Conserving Surgery
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 7, 2018 Category: Cancer & Oncology Source Type: news
Merit Puts a Bow On Cianna Medical Acquisition
Merit Medical Systems has completed the acquisition of Aliso Viejo, CA-based, Cianna Medical. The South Jordan, UT-based company put an upfront payment of $135 million with potential earn-out payments of an additional $15 million for achievement of supply chain and scalability metrics, and up to an additional $50 million for achievement of sales milestones.
Merit said that Cianna specializes in wire-free breast localization and has been focused on breast conservation for 11 years. Its research, development and commercialization teams developed a non-radioactive, wire-free breast localization system and technology that uses...
Source: MDDI - November 14, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'
(American Society for Radiation Oncology) A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report. These 12-year follow-up data from the only prospective, randomized trial to compare recurrence outcomes after treatment for low-risk ductal carcinoma in situ (DCIS) were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news
When Opioids for Cancer Pain Go Wrong: Clin Onc News Report
(MedPage Today) -- Also, breast-conserving surgery or mastectomy? (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - August 15, 2018 Category: OBGYN Source Type: news
Hologic buys Faxitron for $85M
Moving to expand its presence in the breast-conserving surgery market, women's...Read more on AuntMinnie.comRelated Reading:
Hologic appoints new CFO
Hologic wins $4.8M in patent lawsuit against Minerva
Judge finds in favor of Hologic in Fujifilm patent lawsuit
Faxitron acquires Precision X-Ray assets
FDA clears Faxitron's 3D CT breast system
Faxitron to double sales team in 2018 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 2, 2018 Category: Radiology Source Type: news
Could Faxitron Really Be the Perfect Tuck-in for Hologic?
In a move to broaden and further strengthen its breast health portfolio, Hologic said it has acquired digital specialist Faxitron Bioptics for $85 million.
Tucson, AZ-based Faxitron markets a broad portfolio of products across major categories including digital specimen radiography, breast lesion localization, and sentinel lymph node biopsy. The company most recently launched the VisionCT. The technology is a 3-D breast specimen-designated CT system to offer 360-degree images of excised lesions.
“Faxitron's market-leading products, which span from digital specimen radiography to breast lesion localization...
Source: MDDI - August 1, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Potential New Surgical Options for Women with Multiple Ipsilateral Breast Cancer
A newly published collaborative national study finds that most women with two or three sites of cancer in a single breast can successfully complete breast conservation therapy rather than mastectomy. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - July 16, 2018 Category: Hospital Management Authors: Geisel Communications Tags: News Research breast cancer Norris Cotton Cancer Center Source Type: news
Potential new surgical options for women with multiple ipsilateral breast cancer
(Dartmouth-Hitchcock Medical Center) Initial results of a new national clinical trial show that the majority of women with breast cancer who have two to three sites of disease in a single breast at the time of diagnosis are able to successfully complete breast-conserving surgery without conversion to mastectomy. This is the first prospective study to assess this possibility, and its findings improve the surgical choices available to women with multiple ipsilateral breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2018 Category: Cancer & Oncology Source Type: news
Meta-analysis: Recurrence Rates After Lumpectomy Have Improved Meta-analysis: Recurrence Rates After Lumpectomy Have Improved
More than ever before, breast-conserving surgery is a treatment option for more breast cancer patients, say experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Medicaid expansion in Kentucky improves breast cancer care for women 20 to 64 years old
(American College of Surgeons) In Kentucky, one of the Medicaid expansion states, a University of Louisville study of breast cancer care has found a connection between Medicaid expansion and improved quality of breast cancer care, including an increase in diagnosis of early stage disease and greater utilization of breast-conserving surgery instead of more invasive operations such as mastectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news
Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial
This research article has led to a Practice Changing Update in DynaMed Plus. It concludes that radioactive seed localization may have similar positive margin but higher successful placement rates compared to wire localization in women having breast-conserving surgery for nonpalpable invasive breast cancer or ductal carcinoma in situ (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 18, 2018 Category: Consumer Health News Source Type: news
FDA clears Xcision Medical ’ s GammaPod breast cancer device
The FDA said today that it granted 510(k) clearance to the GammaPod stereotactic radiotherapy device made by Xcision Medical Systems to treat breast cancer.
The federal safety watchdog said the GammaPod is designed to treat a portion of the breast in conjunction with breast-conserving surgery. It uses an array of 36 Cobalt-60 sources to beam radiation from within a two-layer vacuum cup that immobilizes the breast to minimize damage to adjacent healthy tissue.
GammaPod is not intended to replace whole-breast radiation therapy and has not been shown to be as effective as that technique, the FDA said. The clearance was b...
Source: Mass Device - December 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Radiosurgery Regulatory/Compliance xcisionmedicalsystems Source Type: news
Women not getting recommended breast radiation therapy
Almost 10% of women don't receive radiation therapy after breast conservation...Read more on AuntMinnie.comRelated Reading:
ASTRO: Breast radiation 'less scary' than expected
JCO releases new sentinel node biopsy guidelines
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news
Why More Women Are Getting a Double Mastectomy
Recent research has shown that despite more having more treatment options, women with cancer in one breast are increasingly choosing to remove both breasts—even though experts in the field say the procedure is not necessarily accompanied by better outcomes.
Now, a new study published Wednesday in JAMA Surgery finds that the increase is being driven in part by their surgeons.
Doctors generally discourage contralateral prophylactic mastectomy—also known as CPM, or the removal of a healthy breast when the other has cancer—for women at an average risk for additional breast cancer. They do recommend it for wo...
Source: TIME.com: Top Science and Health Stories - September 13, 2017 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Breast Cancer breast cancer treatment contralateral prophylactic mastectomy double mastectomy lumpectomy symptoms breast cancer Source Type: news
Dune Medical relocates US HQ to Atlanta
Dune Medical Devices said today it is relocating its US headquarters to Alpharetta, Ga., near Atlanta, from Paoli, Penn. as the company looks to expand its portfolio and improve uptake and reimbursement for its MarginProbe device.
The MarginProbe is a breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries, the company said.
The system uses the company’s proprietary radiofrequency spectroscopy technology to help surgeons identify microscopic residual cancer at surgical margins during surgery.
“Dune’s proprietary technology is already demonstrating high value...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dune Medical Devices Inc. Source Type: news
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
(Wiley) A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2017 Category: International Medicine & Public Health Source Type: news
Effect of Radiotherapy in Breast Cancer Similar Across Subtypes
Breast cancer subtypes generally did not respond differently to radiotherapy following breast-conserving surgery, according to long-term follow-up of a randomized trial. (Source: CancerNetwork)
Source: CancerNetwork - August 5, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Radiation Oncology Source Type: news
